Vaxcyte Inc. Common Stock vs Trane Technologies plc — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 10× Vaxcyte Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals.
| PCVX | TT | |
|---|---|---|
Market Cap | $10.51B | $105.17B |
Volume | 2,644,694 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $73.82 | $503.46 |
52-Week Low | $40.32 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $9.14B | $108.47B |
Dividend Yield | — | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →